Toyonori Omori Selected Research

Lung Neoplasms (Lung Cancer)

7/2015

Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toyonori Omori Research Topics

Disease

3	Malignant Mesothelioma 12/2019 - 07/2015
2	Neoplasms (Cancer) 12/2019 - 07/2016
2	Inflammation (Inflammations) 12/2019 - 07/2014
2	Stroke (Strokes) 01/2015 - 11/2011
2	Mesothelioma 07/2014 - 12/2012
2	Osteoporosis 12/2011 - 01/2010
1	Threatened Abortion 04/2019
1	Venous Thromboembolism 04/2019
1	Infections 01/2019
1	Stillbirth 01/2019
1	Hydrothorax 07/2015
1	Asbestosis 07/2015
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Pleural Diseases 07/2014
1	Carcinogenesis 01/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Hyperplasia 01/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2014
1	Postmenopausal Osteoporosis 12/2011
1	Bone Resorption 12/2011
1	Metabolic Bone Diseases (Osteopenia) 01/2010

Drug/Important Bio-Agent (IBA)

5	AsbestosIBA 12/2019 - 12/2012
3	Carbon Nanotubes (Carbon Nanotube)IBA 07/2016 - 12/2012
2	IsoflavonesIBA 12/2011 - 01/2010
1	ChemokinesIBA 12/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	LigandsIBA 12/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2019
1	ORALIT (ORS)IBA 01/2019
1	Chemokine CCL3IBA 07/2015
1	Unithiol (DMPS)IBA 01/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 07/2014
1	Zinc Oxide FDA Link 01/2014
1	diisopropanolnitrosamineIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 12/2011
1	deoxypyridinolineIBA 12/2011
1	OsteocalcinIBA 12/2011
1	Alkaline PhosphataseIBA 12/2011
1	SaltsIBA 11/2011

Therapy/Procedure

2	Cesarean Section (Caesarean Section) 04/2019 - 01/2019
1	Therapeutics 12/2019
1	Secondary Prevention 01/2015